CVE-2026-21980 Missing authorization in Oracle Life Sciences Central Coding
Unauthenticated attackers can read and modify data in Oracle Life Sciences Central Coding via HTTP.
- Exploited in the wild
- Not known
- Login needed
- Not needed
- Attackable
- Over the internet
- Victim action needed
- Not needed
- Fix
- None listed
What is CVE-2026-21980?
CVE-2026-21980 is a medium-severity missing authorization vulnerability in Oracle Life Sciences Central Coding, published on 20 Jan 2026. An attacker can exploit it over the internet without logging in, with no action from the victim.
Official description
Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
Which versions are affected by CVE-2026-21980?
It affects 1 product.
Products include Oracle Life Sciences Central Coding.
How do I fix CVE-2026-21980?
No fix has been published for CVE-2026-21980 yet. Limit exposure of the affected software until one is available.
Upgrade, and check permissions on every request on the server, not only in the interface. More about Missing authorization.
Is CVE-2026-21980 being exploited?
There is no known exploitation of CVE-2026-21980 in the wild and no public exploit code.
Sources
Also known as GHSA-xxf9-4c23-v3mw.